Larimar Therapeutics Inc (LRMR)
2.34 x 10 2.35 x 32
Post-market by (Cboe BZX)
2.35 -0.05 (-2.08%) 03/28/25 [NASDAQ]
2.34 x 10 2.35 x 32
Post-market 2.35 unch (unch) 16:00 ET
for Fri, Mar 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 90,890 | 41,758 | 36,526 | 50,465 | 42,804 |
| Operating Income | -90,890 | -41,758 | -36,526 | -50,465 | -42,804 |
| Other Income | 10,286 | 4,809 | 1,171 | -171 | 322 |
| Pre-tax Income | -80,604 | -36,949 | -35,355 | -50,636 | -42,482 |
| Net Income Continuous | -80,604 | -36,949 | -35,355 | -50,636 | -42,482 |
| Net Income | $-80,604 | $-36,949 | $-35,355 | $-50,636 | $-42,482 |
| EPS Basic Total Ops | -1.32 | -0.84 | -1.37 | -2.95 | -3.57 |
| EPS Basic Continuous Ops | -1.32 | -0.84 | -1.37 | -2.95 | -3.58 |
| EPS Diluted Total Ops | -1.32 | -0.84 | -1.37 | -2.95 | -3.57 |
| EPS Diluted Continuous Ops | -1.32 | -0.84 | -1.37 | -2.95 | -3.58 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.84 | -1.37 | -2.95 | -3.57 |
| EBITDA(a) | $-95,828 | $-43,290 | $-36,982 | $-50,153 | $-42,639 |